Teaching and Speaking Engagements
Virtual live streaming or in-person conferences for audiences of 20 to 300 people, our consultants are invited speakers at industry conferences and government forums. Our presentations and breakout sessions are customized to meet the conference’s desired outcomes and the audience’s expectations.
Some members of Rowinski Group are also teaching faculty in Master/PhD degree programs for U.S. universities. We use a case study approach to demonstrate in practical terms to the students the commercial value of reimbursement in reducing the business risks inherent with transitioning medical technologies from the academic setting to the commercial clinical market. To date we have had taught almost (1000) students.
A summary of where we have taught and presented since 2004 can be found below. We welcome inquiries.
2022
Wyss Institute- University of Pittsburgh,
University of Michigan Regenerative Medicine Resource Center,
“Why Grant Reviewers are taking a closer review of Reimbursement Mechanisms in Applications”
University of Michigan,
Department of Bio-Medical Engineering,
“Why Reimbursement is Important for Product Adoption”
Santa Clara University,
Department of Bio-Engineering,
“The Critical Importance of Incorporating Reimbursement Planning into the R&D phase”
Georgia Institute of Technology,
Master of Biomedical Innovation and Development Program,
“Reimbursement and Monetization Planning and Implementation for the U.S. Market”
2021
Japan External Trade Organization
“Avoiding a Major U.S. Reimbursement Planning Mistake”.
Georgia Institute of Technology,
Master of Biomedical Innovation and Development Program,
“Reimbursement and Monetization Planning and Implementation for the U.S. Market”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
2020
National Institutes of Health (NIH) /LARTA Commercialization Assistance Program Workshop,
“Regulatory and Reimbursement Planning Issues”
Georgia Institute of Technology,
Master of Biomedical Innovation and Development Program,
“Reimbursement and Monetization Planning and Implementation for the U.S. Market”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
Fast Forward Medical Innovations
Medical School- University of Michigan,
“Reimbursement Considerations for Successful University Licensing Transfers, Spinoffs and Start-Ups”
2019
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
Georgia Institute of Technology,
Master of Biomedical Innovation and Development Program,
“ Reimbursement and Monetization Planning and Implementation for the U.S. Market”
University of California- San Francisco and Berkeley
Master of Medical Translational Program,
“U.S. Reimbursement & Monetization Planning and Implementation”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
2018
MedTech Reimbursement Summit, sponsored by CBI
“Using Payer Data to Solve Complex Business Problems”
Fast Forward Medical Innovations
Medical School- University of Michigan,
“Reimbursement Considerations for Successful University Licensing Transfers, Spinoffs and Start-Ups”
Georgia Institute of Technology,
Master of Biomedical Innovation and Development Program,
“Reimbursement and Monetization Planning and Implementation for the U.S. Market”
University of California- San Francisco and Berkeley
Master of Medical Translational Program,
“U.S. Reimbursement & Monetization Planning and Implementation”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
2017
Georgia Institute of Technology,
Master of Biomedical Innovation and Development Program,
“Reimbursement and Monetization Planning and Implementation for the U.S. Market”
San Jose State University
“Medical Device Reimbursement in a Connected World”
University of California- San Francisco and Berkeley
Master of Medical Translational Program,
“U.S. Reimbursement & Monetization Planning and Implementation”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
Fast Forward Medical Innovations
Medical School- University of Michigan,
“Reimbursement Considerations for Successful University Licensing Transfers, Spinoffs and Start-Ups“
2016
University of California- San Francisco and Berkeley
Master of Medical Translational Program,
“U.S. Reimbursement & Monetization Planning and Implementation”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
2015
National Institutes of Health (NIH) /LARTA Commercialization Assistance Program Workshop,
“Regulatory and Reimbursement Planning Issues”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
University of California- San Francisco and Berkeley
Master of Medical Translational Program,
“U.S. Reimbursement & Monetization Planning and Implementation”
Taiwan Center for Drug Evaluation,
Division of Health Technology Assessment,
“Unique Characteristics of the U.S. Health Insurance Market and the Impact on your U.S. Reimbursement Planning Efforts”
LARTA Commercialization Assistance Webinar Series,
“Key Drivers of Reimbursement Strategy Development for Medical Device, Diagnostic and Digital Healthcare Solutions”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
Surgical Innovations Grand Rounds,
University of California, San Francisco
“Reimbursement Considerations for Successful Medical Device Start-ups”.
2014
Purdue University,
Krannert School of Business, BME 595/MGMT 590 Biomedical Entrepreneurship and Innovation,
“Reimbursement Strategies for Company Business Plans”
National Institutes of Health (NIH) /LARTA Commercialization Assistance Program Workshop,
“Regulatory and Reimbursement Planning Issues”
University of California- San Francisco and Berkeley
Master of Medical Translational Program,
“U.S. Reimbursement & Monetization Planning and Implementation”
Medical Devices Summit, Sponsored by Opal Events
“How Smart Phone Telemedicine is Changing Healthcare Delivery and Reimbursement”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
2013
CEO Leadership Series, Sacramento Area Regional Technology Alliance (SARTA),
“Key Reimbursement Decisions that Could Affect your Fundraising and Commercial Success”
University of California- San Francisco and Berkeley
Master of Medical Translational Program,
“U.S. Reimbursement & Monetization Planning and Implementation”
Taiwan Ministry of Economic Affairs & Industrial Development Bureau
“How Reimbursement Planning Impacts U.S. Commercial and Product Development Plans”
National Institutes of Health (NIH) /LARTA Commercialization Assistance Program Workshop,
“Regulatory and Reimbursement Planning Issues”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
2012
Chinese- American Biopharmaceutical Society,
“Key Reimbursement Decisions You Need to Make Before the U.S. Launch of Your Combination Device”
Center for Technology Commercialization,
University of Kansas,
“Why & How Reimbursement Impacts the Funding, Development and Launch of your UK Start-Up”
Medical Innovation Center,
University of Michigan,
“Reimbursement Decisions to Support Your Fundraising and Commercial Efforts in the Diagnostic and Medical Device Markets”
LARTA Commercialization Assistance Webinar Series,
“Key Drivers of Reimbursement Strategy Development for Medical Device, Diagnostic and Digital Healthcare Solutions”
Taiwan Industrial Technology Research Institute (ITRI),
“Designing your Reimbursement Strategy to Support your U.S. Commercial Objectives”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
2011
National Institutes of Health (NIH) /LARTA Commercialization Assistance Program Workshop,
“Regulatory and Reimbursement Planning Issues”
Purdue University, Krannert School of Business, BME 595/MGMT 590 Biomedical Entrepreneurship and Innovation,
“Reimbursement Strategies for Company Business Plans”
Burrill Digital Health Conference,
“Perspectives on Reimbursement Issues for Digital Healthcare”
Silicon Valley Entrepreneur Program,
Astia Investment & Incubator,
“Why Reimbursement Matters to Investors”
Purdue Research Park Entrepreneurship Academy,
Purdue University,
“Key Drivers of Reimbursement Strategies for Diagnostics and Medical Devices”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
LARTA Commercialization Assistance Webinar Series,
“Key Drivers of Reimbursement Strategy Development for Medical Device, Diagnostic and Digital Healthcare Solutions”
2010
CEO Leadership Series, Sacramento Area Regional Technology Alliance (SARTA),
“Key Reimbursement Decisions that Could Affect your Fundraising and Commercial Success”
Center for Innovation and Company Formation,
Purdue University,
“Key Drivers of Reimbursement Strategy Development and Planning for Medical Devices”
National Institutes of Health (NIH) /LARTA Commercialization Assistance Program Workshop,
“Regulatory and Reimbursement Planning Issues”
Purdue University,
Krannert School of Business, BME 595/MGMT 590 Biomedical Entrepreneurship and Innovation,
“Reimbursement Strategies for Company Business Plans”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
Silicon Valley Entrepreneur Program,
Astia Investment & Incubator,
“Why Reimbursement Matters to Investors”
2009
Medical Innovation Center,
University of Michigan,
“Proactive Reimbursement Planning based on Product Development Cycles”
Silicon Valley Entrepreneur Program,
Astia Investment & Incubator,
“Why Reimbursement Matters to Investors”
Purdue University,
Krannert School of Business, BME 595/MGMT 590 Biomedical Entrepreneurship and Innovation,
“Reimbursement Strategies for Company Business Plans”
University of Michigan,
Department of Bio-Medical Engineering BME 599 Graduate Innovative Design,
“Why Reimbursement is Important for Product Adoption”
2008
CEO Forum Medical Device Manufacturers Association (MDMA),
“Proactive Reimbursement Planning based on Product Development Cycles”
University of California- Berkeley Extension,
“Developing U.S. Reimbursement & Health Economic Strategies for Medical Devices”
HealthEconomics.com,
“Will the Ongoing Medicare Contractor Reform Impact Reimbursement for your Medical Device”
Purdue University,
Krannert School of Business, BME 595/MGMT 590 Biomedical Entrepreneurship and Innovation,
“Reimbursement Strategies for Company Business Plans”
Silicon Valley Entrepreneur Program,
Astia Investment & Incubator,
“Why Reimbursement Matters to Investors”
2007
Biotechnology Management and Entrepreneurship Seminar Series,
Rensselaer Polytechnic Institute,
“Why Reimbursement Planning Should Begin Early in the Product Development Cycle”
University of California- Berkeley Extension,
“Developing U.S. Reimbursement & Health Economic Strategies for Medical Devices”
Silicon Valley Entrepreneur Program,
Astia Investment & Incubator,
“Why Reimbursement Matters to Investors”
Purdue University,
Krannert School of Business, BME 595/MGMT 590 Biomedical Entrepreneurship and Innovation,
“Reimbursement Strategies for Company Business Plans”
2006
University of California- Berkeley Extension,
“Developing U.S. Reimbursement & Health Economic Strategies for Medical Devices”
Purdue University,
Krannert School of Business, BME 595/MGMT 590 Biomedical Entrepreneurship and Innovation,
“Reimbursement Strategies for Company Business Plans”
Silicon Valley Entrepreneur Program,
Astia Investment & Incubator,
“Why Reimbursement Matters to Investors”
2005
University of California- Berkeley Extension,
“Developing U.S. Reimbursement & Health Economic Strategies for Medical Devices”
University of California-Santa Cruz Extension,
“The Impact of U.S. Health Care System on Marketing Biotech Products”
2004
Haas School of Business,
University of California-Berkeley Executive Development,
“Pricing and Reimbursement”
Medical Marketing Association – National Convention,
“Communicating Equivocal Device Trial Results to the Medical Community”
Medical Marketing Association- Southern California Regional Convention,
“A Successful Strategy to Securing Reimbursement Prior to FDA Approval, Medical Marketing Association”
Learn about another of our services “Reimbursement Consulting, Planning and Implementation“.